Traditional Chinese medicine for treating chronic lymphocytic leukemia

Abstract

The invention relates to the field of medicinal formulations, particularly relates to a traditional Chinese medicine for treating chronic lymphocytic leukemia, which is characterized in that the traditional Chinese medicine comprises the following raw materials in percentage by weight: 6-9% of Artemisia capillaris, 11-14% of Platycladus orientalis leaf, 10-13% of Akebia quinata, 4-6% of Agrimonia pilosa, 5-8% of Resina Taxicodendri, 1-2% of Pinellia ternate, 6-8% of Dioscorea bulbifera, 4-7% of Rhizoma Chuanxiong, 2-4% of Lonmicera japonica stem, 3-5% of Placenta Hominis, 2-5% of Galium paradoxum, 2-4% of Ligustrum lucidum fruit, 3-5% of blighted wheat, 2-4% of Iris lactea seed, 3-5% of Taraxacum mongolicum, 5-7% of Asparagus cochinchinensis, 6-9% of Paeonia suffruticosa bark, and 2-4% of Rhizoma Polygonati. The preparation method includes the steps of grinding Placenta Hominis into fine powder, soaking the rest raw materials in water, decocting, filtering, removing residue, collecting filtrate, and adding Placenta Hominis fine powder into the filtrate. The traditional Chinese medicine has low cost, high therapeutic effect on chronic lymphocytic leukemia, and no toxic or adverse effect, and has effects of strengthening body resistance, nourishing yin, tonifying yang, invigorating qi, promoting blood circulation, tonifying kidneys, replenishing essence, strengthening the spleen, nourishing the stomach, softening hardness, eliminating stagnation, smoothing collaterals and relieving pain.

Description

technical field [0001] The invention relates to a Chinese patent medicine preparation, in particular to a traditional Chinese medicine for treating chronic lymphocytic leukemia. Background technique [0002] As we all know, leukemia is a malignant clonal disease of hematopoietic stem cells. Leukemia cells stagnate at different stages of cell development due to enhanced self-renewal of leukemia cells, uncontrolled proliferation, impaired differentiation, and blocked apoptosis. In bone marrow and other hematopoietic tissues, leukemia cells A large amount of hyperplasia accumulates, inhibits normal hematopoiesis and infiltrates other organs and tissues. According to the degree of maturity of leukemia cells and the natural course of the disease, leukemia is divided into two categories: acute and chronic. Chronic lymphocytic leukemia is a disease of monoclonal small lymphocytes. Cells replicate and proliferate at a normal or higher than normal rate, and accumulate in large quant...

AI Technical Summary

Problems solved by technology

A course of chemotherapy costs several thousand to twenty to thirty thousand yuan, and usually requires several or even dozens of courses of treatment. The patient's immunity is also weakened day by day, and infections and complications increase, which brings great financial burden and mental burden to the patient. pain

Images